Clinical Trial Update: A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial of PROSTVAC-V/F with or without GM-CSF in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• PROSTVAC-V/F

Snippet

Sponsor: Bavarian Nordic | Conditions: Prostate Cancer Metastatic | Phase 3 | Status: COMPLETED | Results posted: 2019-08-08